PolarCool AB (publ) is a medical device company that develops, markets, and sells products for sports medicine. The company focuses on treatment of concussive and sub-concussive brain injury with the portable cooling device PolarCap® System. PolarCool AB (publ) is based in Lund, Sweden.
The company was founded as a subsidiary of BrainCool AB (publ) at the end of 2016. PolarCool plans to list its shares on Spotlight Stock Market in November of 2018, preceded by an Initial Public Offering with subscription period October 9-23, 2018.
PolarCool’s vision is that cooling becomes a standard treatment of head trauma within sports and recreational activities, thereby limiting brain injury in contact and combat sports.
Our business idea
PolarCool’s business idea is to provide PolarCap® System which can swiftly reduce the brain temperature of individuals suffering from a concussion or participating in an activity where repetitive head impact occurs. Our solution is based on the scientific hypothesis that medical cooling can relieve symptoms, prevent the development of long-term chronic brain injuries, and accelerate recovery.
PolarCool’s strategy entails marketing and sales to athletes and organizations participating in activities where concussions and repetitive head collisions are commonplace. In addition, through continued clinical trials, PolarCool will demonstrate the benefit of cooling as well as the efficacy of PolarCap® System.
PolarCool’s objective is to have the portable brain cooling device PolarCap® System available for athletes, teams, and organizations.